The BU CTSI seeks to submit to the NIH two diversity supplements to our current Clinical and Translational Science Institute award. The goal of these supplements is to build a diverse clinical and translational research workforce that is prepared to improve the quality, safety, efficiency, and speed of clinical and translational science research nationally. Diversity supplements provide opportunities (salary, fringe benefits, travel, and limited supplies) to improve the diversity of the research workforce by supporting early-career researchers from diverse backgrounds, including those from groups that are underrepresented in medicine and health-related research.

Please note that if an individual who has received previous funding from NIH as an independent PD/PI on a research grant (e.g., R01, R03, R21), as the project leader on a component of a program project or center grant (e.g., UL1, P01, P50, G12), or as PD/PI on an individual research career development award (e.g., K01, K02, K07, K08, and K23), or as a Scholar on an Institutional Career Development Award (K12, KL2) is not eligible as a diversity supplement candidate.

We strive to have a transparent and equitable process to decide the two individuals who will submit competitive diversity supplement applications for our CTSI to the NIH.  Therefore, we are requesting applications from interested and eligible candidates; a CTSI review team will select the top applications, and then the CTSI team will work with these individuals to further develop their NIH Diversity supplement application. These supplements, if awarded by NIH, provide 2 years of support to engage in training and research, similar to a Career Development Award. Learn more


BU CTSI RFA Release Date: August 2, 2022
BU CTSI Application/Expression of Interest Deadline: September 16, 2022
Sponsor (CTSA/NCATS) Application Due date: November 1, 2022

Submit Application Here